Skip to main content
Log in

Protective effect of tanshinone II A on signal transduction system protein kinase B in rats with myocardial hypertrophy

  • Research Article
  • Published:
Frontiers of Medicine in China Aims and scope Submit manuscript

Abstract

The effects of tanshinone II A on cell signal transduction system protein kinase B in rats with myocardial hypertrophy induced by the abdominal aorta partial coarctation were investigated. Rat models of myocardial hypertrophy were established by using abdominal aorta partial coarctation method. Forty-eight rats were randomly divided into sham group (S group), model group (M group), valsartan treatment group (X group), low-dose tanshinone treatment group (LD group), medium-dose tanshinone treatment group (MD group), and high-dose tanshinone treatment group (HD group) (n = 8 in each group). Left ventricular mass index (LVMI), left ventricular posterior wall (LVPW), and septal thickness (IVS) were detected by high frequency ultrasonography. Myocardial fiber diameter (MFD) was examined by Hematoxylin-Eosin (HE) staining, and the contents of phosphorylated protein kinase B (p-Akt) and p-Gsk3β in myocardium were assayed by Western blot. The results showed that compared with S group, the values of LVMI, LVPW, IVS and MFD were increased in other groups (P<0.05), and the contents of p-Akt, and p-Gsk3β were also increased in other groups. As compared with MD group, the values of LVMI, LVPW, IVS and MFD were decreased in all treatment groups (P<0.05), and the contents of p-Akt, and p-Gsk3β were also decreased in all treatment groups. However, there were no significant differences among LD, MD, and HD groups (P>0.05), and there were no significant differences between X group and tanshinone treatment groups (P>0.05). It was suggested that tanshinone II A could prevent myocardial hypertrophy by its action on the Akt signaling pathway.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Kang Y J. Cardiac hypertrophy: a risk factor for QT2prolon2 gation and cardiac sudden death. Toxicol Pathol, 2006, 34(10): 58–66

    Article  CAS  PubMed  Google Scholar 

  2. Sun L P, Zheng Z. The effects of sodium tanshinone II A sulfonate on activation of NF-κB on hypertrophic myocardial cells. Shiyong Laonian Yixue, 2004, 18(1): 25–27 (in Chinese)

    CAS  Google Scholar 

  3. Xu S Y, Bian R L, Chen X. Pharmacological experiments methodology. Beijing: People’ Health Press, 2002, 1026–1028

    Google Scholar 

  4. Frey N, Olson E N. Cardiac hypertrophy: the good, the bad, and the ugly. Ann Rev Physiol, 2003, 65: 45–79

    Article  CAS  Google Scholar 

  5. James M A, Saadeh A M, Jones J V. Wall stress and hypertension. J Cardiovasc Risk, 2000, 30(7): 187–190

    Google Scholar 

  6. Spirito P, Autore C. Management of hypertrophic cardiomyopathy. BMJ, 2006, 322(7552): 1251–1255

    Article  Google Scholar 

  7. Hu J, Zhang C T, Pu J, Quan X Q, Lv J G, Bai R, Wei Y, Zeng X L. Effects of Perindopril on Ventricular Arrhythmias in Rabbits with Cardiac Hypertrophy. Hua Zhong Ke Ji Da Xue Xue Bao (Yi Xue Ban), 2008, 37(5): 688–690 (in Chinese)

    Google Scholar 

  8. Ke J, Zhang C T, Ma Y X, Liu J, Liu N, Ruan Y F, Lin L. The Roles of Calmodulin Kinase II Inhibitor in Ventricular Arrhythmias in Rabbits with Cardiac Hypertrophy. Hua Zhong Ke Ji Da Xue Xue Bao (Yi Xue Ban), 2007, 36(2): 183–190 (in Chinese)

    CAS  Google Scholar 

  9. Li L F, Chen L W. The mechanisms of myocardial hypertrophy. Hai Nan Yi Xue, 2008, 19(7): 123–125 (in Chinese)

    CAS  Google Scholar 

  10. Wang Y. Signal transduction in cardiac hypertrophy-dissecting compensatory versus pathological pathways utilizing a transgenic approach. Curr Opin Pharmacol, 2001, 41(1): 134–140

    Article  Google Scholar 

  11. Morisco C, Zebroski D, Condorelli G. The Akt-glycogen synthase kinase 3β pathway regulates transcription atrial natriiuretic factor induced by β-adrenergic receptor stimulation in cardiac myocytes. J Biol Chem, 2000, 275(19): 14466–14475

    Article  CAS  PubMed  Google Scholar 

  12. Matsui T, Nagoshi T, Rosenzweig A. Akt and PI 3-kinase signaling in cardiomyocyte hypertrophy and survival. Cell Cycle, 2003, 2(3): 220–223

    CAS  PubMed  Google Scholar 

  13. Cao W, Shi F X, Phosphodiesterase type 3B: Downstream Factor of PI3k/PKB pathway as well as its clinical research, Xi Bao ShengWu Xue Za Zhi, 2007, 29(6): 800–804 (in Chinese)

    CAS  Google Scholar 

  14. Frame S, Cohen P. GSK3 takes centre stage more than 20 years after its discovery. Biochem J, 2001, 359(1): 1–16

    Article  CAS  PubMed  Google Scholar 

  15. Antos C L, McKinsey T A, Frey N, Kutschke W, McAnally J, Shelton J M, Richardson J A, Hill J A, Olson E N. Activated glycogen synthase-3β suppresses cardial hypertrophy in vivo. Proc Natl Acad Sci USA, 2002, 99(2): 907–912

    Article  CAS  PubMed  Google Scholar 

  16. Shio Jima I, Walsh K. Regulation of cardiac growth and coronary angiogenesis by the Akt/PKB signaling pathway. Genes Dev, 2006, 20(24): 3347–3365

    Article  CAS  Google Scholar 

  17. Heineke J, Molkentin J D. Regulation of cardiac hypertrophy by intracellular signaling pathways. Nat Rev Mol Cell Biol, 2006, 7(8): 589–600

    Article  CAS  PubMed  Google Scholar 

  18. Balakumar P, Singh M. The possible role of caspase-3 in pathological and physiological cardiac hypertrophy in rats. Basic Clin Pharmacol Toxicol, 2006, 99(6): 418–424

    Article  CAS  PubMed  Google Scholar 

  19. Gao N, Flynn D C, Zhang Z. G1 cell cycle progression and the expression of G1 cyclins are regulated by PI3K/AKT/mTOR/ p70S6K1 signaling in human ovarian cancer cells. Am J Physiol Cell Physiol, 2004, 287(2): C281–C291

    Article  CAS  PubMed  Google Scholar 

  20. Matsui T, Li L, Wu J C, Cook S A, Naqoshi T, Picard M H, Liao R, Rosenzweiq A. Phenotypix spectrum caused by transgenic overexpression of activated Akt in the heart. J Biol Chem, 2002, 277(25): 22896–22901

    Article  CAS  PubMed  Google Scholar 

  21. Shioi T, Mcmullen J R, Kang P M, Douqlas P S, Obata T, Franke T F, Cantley L C, Izumo S. Akt/Protein kinase B promotes organ growth in transgenic mice. Mol Cell Biol, 2002, 22(8): 2799–2809

    Article  CAS  PubMed  Google Scholar 

  22. McMullen J R, Izumo S. Role of the insulin-like growth factor 1 (IGF1)/phosphoinositide-3-kinase (PI3K) pathway mediating physiological cardiac hypertrophy. Novartis Found Symp, 2006, 274: 90–111

    Article  CAS  PubMed  Google Scholar 

  23. Zhou Y, Zhang J P, Wu M H, Liu H, Zhao Z G, He S Y, Wang Y T, Chu L. Influence of “YiQi Qiang Xin Decoction” on pressure overload myocardial hypertrophy. Shang Hai Zhong Yi Yao Za Zhi, 2008, 42(5): 80–82 (in Chinese)

    Google Scholar 

  24. Sun L P, Zheng Z. The Effect of Salvia Miltiorrhiza Bge on left ventricular hypertrophy and the expression of tumor necrosis factor-α in spontaneously hypertensive rats. Gao Xue Ya Za Zhi, 2004, 12(3): 238–241 (in Chinese)

    Google Scholar 

  25. Gong L Y, Zheng Z, Xiong W, Sun L P. Tanshinone II A prevents angiotensin II-induced hypertrophy of cardiomyocytes from rat. Hua Xi Yao Xue Za Zhi, 2004, 9(1): 24–27 (in Chinese)

    Google Scholar 

  26. Jiang F L, Feng J, Zheng Z. Effect of sodium tanshinone II-A sulfonate on activation of extracellular signal-regulated kinase 1/2 in angiotensin II-induced cardiomyocyte hypertrophy. Zhong Guo Yao Li Xue Tong Bao, 2008, 24(3): 307–312 (in Chinese)

    CAS  Google Scholar 

  27. Li Y S, Wang Z H, Wang J, Yan L, Yong Y Q, Liang Q S, Zheng Z, Yang G T. Effect of tashinone II A on the nitric oxide synthase gene expression and intracellular Ca∼(2 +) level in the hypertrophic cadiocytes of pressure-overloaded rats. Hua Zhong Ke Ji Da Xue Xue Bao (Yi Xue Ban), 2008, 37(3): 286–289 (in Chinese)

    Google Scholar 

  28. Yang T, Zhang W, Zhang L. Inhibitory effects of L-arginine-nitric oxide pathway on formation of pathological cardiac hypertrophy and the related mechanisms. Di Er Jun Yi Da Xue Xue Bao, 2008, 29(2): 177–183 (in Chinese)

    Google Scholar 

  29. Ouyang X, Takahashi K, Komatsu K, Nakamura N, Hattori M, Baba A, Azuma J. Protective effect of salvia miltiorrhiza on angiotensin II induced hypertrophic responses in neonatal rat cardial cells. Jpn J pharmacol, 2001, 87(4): 289–296

    Article  CAS  PubMed  Google Scholar 

  30. Pan G J, Wang X L. Effect of Radix Salviae Miltiorrhizae (RAM) on myocardiac hypertrophy in rat model of over-loading pressure. Zhong Guo Fen Zi Xin Zhang Bing Xue Za Zhi, 2007, 7(1): 34–36 (in Chinese)

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Guangtian Yang.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tu, E., Pan, Y., Zheng, K. et al. Protective effect of tanshinone II A on signal transduction system protein kinase B in rats with myocardial hypertrophy. Front. Med. China 3, 431–436 (2009). https://doi.org/10.1007/s11684-009-0088-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11684-009-0088-4

Keywords

Navigation